March 29, 2018
EMA accepts BioMarin’s Pegvaliase MAA for treatment of Phenylketonuria (PKU)
European Medicines Agency (EMA) has accepted BioMarin’s submission of a Marketing Authorization Application (MAA) for pegvaliase for the treatment of…